| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |